April 3, 2020: The Week in Cancer News
CAR-T cell therapy may help patients after a relapse of mantle cell lymphoma, and more news of the week...
Progress Against Cancer
CAR-T cell therapy may help patients after a relapse of mantle cell lymphoma, and more news of the week...
People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is...
The FDA has approved a new combination of immunotherapy and chemotherapy as an initial treatment for extensive-stage small cell...
Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
Cancer patients and survivors share tips on how to respond to the coronavirus pandemic, and more news of the...
Guest post by Jeremy Warner, MD, MS, and Deborah Doroshow, MD, PhD The world is facing a pandemic unlike...
Cancer centers are making changes to care for some patients enrolled in trials.
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S....
A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
Barrett’s esophagus is a known risk factor for esophageal cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 47,000 members worldwide drive progress against cancer.
Donate Today